Brief: Bioretec Clarifies 2026-2028 Financial Target Regarding Sales Margin
13/05/2026 12:02
May 13 (Reuters) - Bioretec Oy BRETEC.HE: CLARIFIES ITS 2026-2028 FINANCIAL TARGET REGARDING THE SALES MARGIN TARGETS NET SALES > EUR 10 MILLION AND AVERAGE ADJUSTED SALES MARGIN > 70% FOR 2026-2028 Source text: ID:nWkr8p20pv Further company coverage: BRETEC.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million